Avidity Biosciences (RNA) Return on Sales: 2020-2025
Historic Return on Sales for Avidity Biosciences (RNA) over the last 6 years, with Sep 2025 value amounting to -26.29%.
- Avidity Biosciences' Return on Sales rose 138.00% to -26.29% in Q3 2025 from the same period last year, while for Sep 2025 it was -26.29%, marking a year-over-year increase of 138.00%. This contributed to the annual value of -29.55% for FY2024, which is 742.00% down from last year.
- Latest data reveals that Avidity Biosciences reported Return on Sales of -26.29% as of Q3 2025, which was up 37.97% from -42.37% recorded in Q2 2025.
- In the past 5 years, Avidity Biosciences' Return on Sales registered a high of -7.63% during Q1 2021, and its lowest value of -42.37% during Q2 2025.
- Its 3-year average for Return on Sales is -26.69%, with a median of -23.79% in 2024.
- Examining YoY changes over the last 5 years, Avidity Biosciences' Return on Sales showed a top increase of 138bps in 2025 and a maximum decrease of 2,029bps in 2025.
- Over the past 5 years, Avidity Biosciences' Return on Sales (Quarterly) stood at -12.65% in 2021, then slumped by 621bps to -18.86% in 2022, then tumbled by 328bps to -22.14% in 2023, then tumbled by 742bps to -29.55% in 2024, then spiked by 138bps to -26.29% in 2025.
- Its Return on Sales stands at -26.29% for Q3 2025, versus -42.37% for Q2 2025 and -41.29% for Q1 2025.